Neuronetics, Inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 24/100
What the filing says
Neuronetics adopted a new 2026 Equity Incentive Plan (approved by stockholders May 28, 2026) succeeding the 2018 plan. The plan reserves 5,780,542 shares initially, plus annual 4% increases through 2036, with authority to grant RSUs, options, performance awards, and other equity instruments to employees, directors, and consultants. No specific individual awards are disclosed in this filing—only template grant agreements and the plan framework are exhibited.
Why this rating
Routine equity plan renewal typical for public companies; no material immediate dilution disclosed. Plan size (~5.8M shares) is ~4.5% of market cap ($129.3M), standard for small-cap. Significance below 35—administrative, forward-looking, no binding awards yet granted.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.